Literature DB >> 11158594

Failure of ductus arteriosus closure and remodeling in neonatal mice deficient in cyclooxygenase-1 and cyclooxygenase-2.

C D Loftin1, D B Trivedi, H F Tiano, J A Clark, C A Lee, J A Epstein, S G Morham, M D Breyer, M Nguyen, B M Hawkins, J L Goulet, O Smithies, B H Koller, R Langenbach.   

Abstract

The transition to pulmonary respiration following birth requires rapid alterations in the structure of the mammalian cardiovascular system. One dramatic change that occurs is the closure and remodeling of the ductus arteriosus (DA), an arterial connection in the fetus that directs blood flow away from the pulmonary circulation. A role for prostaglandins in regulating the closure of this vessel has been supported by pharmacological and genetic studies. The production of prostaglandins is dependent on two cyclooxygenases (COX-1 and COX-2), which are encoded by separate genes. We report here that the absence of either or both COX isoforms in mice does not result in premature closure of the DA in utero. However, 35% of COX-2(-/-) mice die with a patent DA within 48 h of birth. In contrast, the absence of only the COX-1 isoform does not affect closure of the DA. The mortality (35%) and patent DA incidence due to absence of COX-2 is, however, significantly increased (79%) when one copy of the gene encoding COX-1 is also inactivated. Furthermore, 100% of the mice deficient in both isoforms die with a patent DA within 12 h of birth, indicating that in COX-2-deficient mice, the contribution of COX-1 to DA closure is gene dosage-dependent. Together, these data establish roles for COX-1, and especially for COX-2, in the transition of the cardiopulmonary circulation at birth.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11158594      PMCID: PMC14708          DOI: 10.1073/pnas.98.3.1059

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

Review 1.  Insight into prostaglandin, leukotriene, and other eicosanoid functions using mice with targeted gene disruptions.

Authors:  S C Austin; C D Funk
Journal:  Prostaglandins Other Lipid Mediat       Date:  1999-11       Impact factor: 3.072

2.  Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs.

Authors:  J R Vane
Journal:  Nat New Biol       Date:  1971-06-23

Review 3.  Patent ductus arteriosus in the neonate.

Authors:  W M Gersony
Journal:  Pediatr Clin North Am       Date:  1986-06       Impact factor: 3.278

Review 4.  Prostaglandin synthetase inhibitors in pregnancy.

Authors:  I B Van den Veyver; K J Moise
Journal:  Obstet Gynecol Surv       Date:  1993-07       Impact factor: 2.347

5.  Developmental changes in prostaglandin E(2) receptor subtypes in porcine ductus arteriosus. Possible contribution in altered responsiveness to prostaglandin E(2).

Authors:  M Bhattacharya; P Asselin; P Hardy; A M Guerguerian; H Shichi; X Hou; D R Varma; A Bouayad; J C Fouron; R I Clyman; S Chemtob
Journal:  Circulation       Date:  1999-10-19       Impact factor: 29.690

6.  Characterization of dilator prostanoid receptors in the fetal rabbit ductus arteriosus.

Authors:  G C Smith; R A Coleman; J C McGrath
Journal:  J Pharmacol Exp Ther       Date:  1994-10       Impact factor: 4.030

7.  Effect of advancing gestational age on the frequency of fetal ductal constriction in association with maternal indomethacin use.

Authors:  K J Moise
Journal:  Am J Obstet Gynecol       Date:  1993-05       Impact factor: 8.661

8.  Characterisation of the effect of oxygen tension on response of fetal rabbit ductus arteriosus to vasodilators.

Authors:  G C Smith; J C McGrath
Journal:  Cardiovasc Res       Date:  1993-12       Impact factor: 10.787

9.  Placental transfer of indomethacin in the human pregnancy.

Authors:  K J Moise; C N Ou; B Kirshon; L E Cano; C Rognerud; R J Carpenter
Journal:  Am J Obstet Gynecol       Date:  1990-02       Impact factor: 8.661

10.  Indomethacin in the treatment of premature labor. Effects on the fetal ductus arteriosus.

Authors:  K J Moise; J C Huhta; D S Sharif; C N Ou; B Kirshon; N Wasserstrum; L Cano
Journal:  N Engl J Med       Date:  1988-08-11       Impact factor: 91.245

View more
  50 in total

Review 1.  Why there are two cyclooxygenase isozymes.

Authors:  W L Smith; R Langenbach
Journal:  J Clin Invest       Date:  2001-06       Impact factor: 14.808

Review 2.  Patent ductus arteriosus: evidence for and against treatment.

Authors:  Ronald I Clyman; Nancy Chorne
Journal:  J Pediatr       Date:  2007-03       Impact factor: 4.406

3.  Regulation of the fetal mouse ductus arteriosus is dependent on interaction of nitric oxide and COX enzymes in the ductal wall.

Authors:  Jeff Reese; Patrick W O'Mara; Stanley D Poole; Naoko Brown; Chelsea Tolentino; Delrae M Eckman; Judy L Aschner
Journal:  Prostaglandins Other Lipid Mediat       Date:  2008-11-13       Impact factor: 3.072

4.  Basal bone phenotype and increased anabolic responses to intermittent parathyroid hormone in healthy male COX-2 knockout mice.

Authors:  Manshan Xu; Shilpa Choudhary; Olga Voznesensky; Qi Gao; Douglas Adams; Vilmaris Diaz-Doran; Qian Wu; David Goltzman; Lawrence G Raisz; Carol C Pilbeam
Journal:  Bone       Date:  2010-05-13       Impact factor: 4.398

5.  Anatomical differences and atherosclerosis in apolipoprotein E-deficient mice with 129/SvEv and C57BL/6 genetic backgrounds.

Authors:  Nobuyo Maeda; Lance Johnson; Shinja Kim; John Hagaman; Morton Friedman; Robert Reddick
Journal:  Atherosclerosis       Date:  2007-02-01       Impact factor: 5.162

Review 6.  Novel drug targets for ductus arteriosus manipulation: Looking beyond prostaglandins.

Authors:  Elaine L Shelton; Gautam K Singh; Colin G Nichols
Journal:  Semin Perinatol       Date:  2018-05-10       Impact factor: 3.300

7.  Genetic contribution to patent ductus arteriosus in the premature newborn.

Authors:  Vineet Bhandari; Gongfu Zhou; Matthew J Bizzarro; Catalin Buhimschi; Naveed Hussain; Jeffrey R Gruen; Heping Zhang
Journal:  Pediatrics       Date:  2009-02       Impact factor: 7.124

8.  Failure of postnatal ductus arteriosus closure in prostaglandin transporter-deficient mice.

Authors:  Hee-Yoon Chang; Joseph Locker; Run Lu; Victor L Schuster
Journal:  Circulation       Date:  2010-01-18       Impact factor: 29.690

9.  Genetic ablation of cyclooxygenase-2 in keratinocytes produces a cell-autonomous defect in tumor formation.

Authors:  Huei-Chen Lao; Jacqueline K Akunda; Kyung-Soo Chun; Gordon P Flake; Stuart H Yuspa; Robert Langenbach
Journal:  Carcinogenesis       Date:  2012-08-17       Impact factor: 4.944

10.  Cyclooxygenase-2 expression in oligodendrocytes increases sensitivity to excitotoxic death.

Authors:  Noel G Carlson; Monica A Rojas; Jonathan W Redd; Philip Tang; Blair Wood; Kenneth E Hill; John W Rose
Journal:  J Neuroinflammation       Date:  2010-04-13       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.